Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00151515 | A Study to Evaluate the Effectiveness and Safety of 5 Percent Minoxidil Foam in the Treatment of Male Pattern Hair Loss | PHASE3 | COMPLETED | 352 | — | — | Oct 1, 2003 | Jul 1, 2004 | Sep 30, 2016 | 15 | United States |
| NCT01319370 | Effectiveness and Safety of Minoxidil Foam Versus Placebo Foam for Androgenetic Alopecia | PHASE2 | COMPLETED | 70 | — | — | Nov 1, 2010 | Mar 1, 2013 | Nov 7, 2013 | 1 | Germany |
| Arm | Type | Description |
|---|---|---|
| 1 | EXPERIMENTAL | Topical 5% minoxidil foam formulation used twice daily |
| vehicle of 5% Minoxidl topical foam | PLACEBO_COMPARATOR | vehicel foam in twice daily application in temple and vertex region |
| 5% Minoxidil topical foam | ACTIVE_COMPARATOR | 5% Minoxidil topical in twice daily application in temple and vertex region |
| Name | Type | Description |
|---|---|---|
| minoxidil | DRUG | Topical 5% minoxidil foam, BID, for sixteen weeks |
| vehicle of 5% Minoxidil topical foam | DRUG | 1 g of vehicle topical foam twice daily over 24 weeks in double-blinded phase and further 80 weeks in open-label-phase |
Inclusion Criteria: * presence of androgenetic alopecia with vertex pattern IIIv, IV, or V on the Norwood Hamilton Scale * Male sex, age 15 to 49, good health * Willingness to have a dot tattoo placed in the target area of the scalp during the study * Willingness to maintain normal shampooing habit...